Related references
Note: Only part of the references are listed.Tailoring the GVHD prophylaxis regimen according to transplantation associated toxicities-Substituting the 3rd dose of methotrexate to mycophenolate mofetil
Ron Ram et al.
LEUKEMIA RESEARCH (2014)
Seroepidemiology of Epstein-Barr virus and cytomegalovirus among Israeli male young adults
Nagai Levine et al.
ANNALS OF EPIDEMIOLOGY (2012)
Evidence for a Bidirectional Relationship between Cytomegalovirus Replication and acute Graft-versus-Host Disease
Nathan Cantoni et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Infections in non-myeloablative hematopoietic stem cell transplantation patients with lymphoid malignancies: spectrum of infections, predictors of outcome and proposed guidelines for fungal infection prevention
A. Safdar et al.
BONE MARROW TRANSPLANTATION (2010)
The risk of early and late CMV DNAemia associated with Campath use in stem cell transplant recipients
H. C. Buyck et al.
BONE MARROW TRANSPLANTATION (2010)
Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
Per Ljungman et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2010)
Cytomegalovirus infection/disease after hematopoietic stem cell transplantation
Takehiko Mori et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection
Michael J. Cannon et al.
REVIEWS IN MEDICAL VIROLOGY (2010)
Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy
B. George et al.
TRANSPLANT INFECTIOUS DISEASE (2010)
Effect of Conditioning Regimen Intensity on CMV Infection in Allogeneic Hematopoietic Cell Transplantation
Hirohisa Nakamae et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective PREFACE
M. Tomblyn et al.
BONE MARROW TRANSPLANTATION (2009)
Cytomegalovirus infection in children who underwent hematopoietic stem cell transplantation at a single center: A retrospective study of the risk factors
Hoi Soo Yoon et al.
PEDIATRIC TRANSPLANTATION (2009)
Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies
E. Oezdemir et al.
BONE MARROW TRANSPLANTATION (2007)
The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy
M Boeckh et al.
BLOOD (2004)
Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megatile analysis
P Ljungman et al.
BLOOD (2003)
Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies
M Boeckh et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Increased risk of complicated CMV infection with the use of mycophenolate mofetil in allogeneic stem cell transplantation
L Hambach et al.
BONE MARROW TRANSPLANTATION (2002)
Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study
C Junghanss et al.
BLOOD (2002)
Share Paper
